Cited by 1,763Wnt/β-catenin signaling in development and cancerHedgehog Signaling Pathway StudiesSignaling Pathways in Disease

WNT and β-catenin signalling: diseases and therapies

Moon, Randall T., Kohn, Aimee D., Ferrari, Giancarlo V. De, Kaykas, Ajamete·2004·Nature Reviews Genetics

Abstract

WNT signalling has been studied primarily in developing embryos, in which cells respond to WNTs in a context-dependent manner through changes in survival and proliferation, cell fate and movement. But WNTs also have important functions in adults, and aberrant signalling by WNT pathways is linked to a range of diseases, most notably cancer. What is the full range of diseases that involve WNT pathways? Can inhibition of WNT signalling form the basis of an effective therapy for some cancers? Could activation of WNT signalling provide new therapies for other clinical conditions? Finally, on the basis of recent experiments, might WNTs normally participate in self-renewal, proliferation or differentiation of stem cells? If so, altering WNT signalling might be beneficial to the use of stem cells for therapeutic means.

Integrity signals

Registry

Crossref · 10.1038/nrg1427

Cites

115 of 115 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Uneven activation of the Wnt/β-catenin pathway has led to the development of a variety of human tumours.

    “Uneven activation of the Wnt/β-catenin pathway has led to the development of a variety of human tumours [56], [57].”
  • When WNT ligands are present, β-catenin degradation is impeded, causing its nuclear translocation and subsequent binding to T-cell factor (TCF), which results in the transcriptional activation of their target genes.

    “When WNT ligands are present, β-catenin degradation is impeded, causing its nuclear translocation and subsequent binding to T-cell factor (TCF), which results in the transcriptional activation of their target genes.443,445,446”
  • Wnt2 and other proteins usually linked to neural development might also play significant roles in regulating neuronal function after critical periods.

    “nonetheless, Wnt2 and other proteins traditionally associated with neural development may have important roles in post-critical period regulation of neuronal function (Farias et al., 2007; Moon et al., 2004; Wayman et al., 2006).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Moon, R. T., Kohn, A. D., Ferrari, G. V. D., & Kaykas, A.
Affiliations
Howard Hughes Medical Institute (US)
Corresponding author
Moon, Randall T.
Venue
Nature Reviews Genetics
Published
2004-09
Volume
5
Issue
9
Pages
691-701
ISSN
  • 1471-0056 (ISSN-L)
  • 1471-0064
OpenAlex
W1967803088
Cited by
1,763
References
115
Citations by year
2026: 17 · 2025: 33 · 2024: 42 · 2023: 33 · 2022: 40 · 2021: 63 · 2020: 67 · 2019: 74 · 2018: 72 · 2017: 86 · 2016: 88 · 2015: 103 · 2014: 103 · 2013: 110 · 2012: 126
FWCI
6.11
Type
journal article
Language
en
Open access
closed
Locations
  • Nature Reviews Genetics (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institutes of Health
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Hedgehog Signaling Pathway Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
Keywords
Wnt signaling, β-catenin, cancer, Wnt inhibitors, cancer therapy, stem cells, self-renewal, cell proliferation, cell differentiation, developmental signalling, disease
MeSH terms
Animals, Cytoskeletal Proteins, Forecasting, Humans, Neoplasms, Proto-Oncogene Proteins, Signal Transduction, Trans-Activators, Wnt Proteins, beta Catenin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review